These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
168 related articles for article (PubMed ID: 35400526)
1. Risk of recurrent disease following conization of cervical intraepithelial neoplasia grade 3 according to post-conization HPV status and surgical margins. Sand FL; Frederiksen K; Kjaer SK Gynecol Oncol; 2022 Jun; 165(3):472-477. PubMed ID: 35400526 [TBL] [Abstract][Full Text] [Related]
2. Incomplete excision of cervical intraepithelial neoplasia as a predictor of the risk of recurrent disease-a 16-year follow-up study. Alder S; Megyessi D; Sundström K; Östensson E; Mints M; Belkić K; Arbyn M; Andersson S Am J Obstet Gynecol; 2020 Feb; 222(2):172.e1-172.e12. PubMed ID: 31473226 [TBL] [Abstract][Full Text] [Related]
3. Risk of cervical intraepithelial neoplasia grade 2 or worse after conization in relation to HPV vaccination status. Sand FL; Kjaer SK; Frederiksen K; Dehlendorff C Int J Cancer; 2020 Aug; 147(3):641-647. PubMed ID: 31648368 [TBL] [Abstract][Full Text] [Related]
4. HPV Test as Test of Cure After Conization for CIN2+: A Nationwide Register-Based Cohort Study. Bruhn LV; Hyldig N; Schledermann D J Low Genit Tract Dis; 2022 Oct; 26(4):287-292. PubMed ID: 36126201 [TBL] [Abstract][Full Text] [Related]
5. Role of human papillomavirus testing and cytology in follow-up after conization. Gosvig CF; Huusom LD; Deltour I; Andersen KK; Duun-Henriksen AK; Madsen EM; Petersen LK; Elving L; Schouenbourg L; Iftner A; Svare E; Iftner T; Kjaer SK Acta Obstet Gynecol Scand; 2015 Apr; 94(4):405-11. PubMed ID: 25645089 [TBL] [Abstract][Full Text] [Related]
6. Long-term follow-up of the risk for cervical intraepithelial neoplasia grade 2 or worse in HPV-negative women after conization. Gosvig CF; Huusom LD; Andersen KK; Duun-Henriksen AK; Frederiksen K; Iftner A; Svare E; Iftner T; Kjaer SK Int J Cancer; 2015 Dec; 137(12):2927-33. PubMed ID: 26139420 [TBL] [Abstract][Full Text] [Related]
7. Pre- and post-conization high-risk HPV testing predicts residual/recurrent disease in patients treated for CIN 2-3. Alonso I; Torné A; Puig-Tintoré LM; Esteve R; Quinto L; Campo E; Pahisa J; Ordi J Gynecol Oncol; 2006 Nov; 103(2):631-6. PubMed ID: 16780934 [TBL] [Abstract][Full Text] [Related]
8. Incomplete excision of cervical precancer as a predictor of treatment failure: a systematic review and meta-analysis. Arbyn M; Redman CWE; Verdoodt F; Kyrgiou M; Tzafetas M; Ghaem-Maghami S; Petry KU; Leeson S; Bergeron C; Nieminen P; Gondry J; Reich O; Moss EL Lancet Oncol; 2017 Dec; 18(12):1665-1679. PubMed ID: 29126708 [TBL] [Abstract][Full Text] [Related]
9. Recurrent high-grade cervical lesion after primary conization is associated with persistent human papillomavirus infection in Norway. Vintermyr OK; Iversen O; Thoresen S; Quint W; Molijn A; de Souza S; Rosillon D; Holl K Gynecol Oncol; 2014 May; 133(2):159-66. PubMed ID: 24631451 [TBL] [Abstract][Full Text] [Related]
10. High-grade CIN on cervical biopsy and predictors of the subsequent cone histology results in women undergoing immediate conization. Giannella L; Mfuta K; Gardini G; Rubino T; Fodero C; Prandi S Eur J Obstet Gynecol Reprod Biol; 2015 Mar; 186():68-74. PubMed ID: 25656975 [TBL] [Abstract][Full Text] [Related]
11. The treatment strategy of patients with positive margins after cervical cold knife conization-A 7-year retrospective study in China. Fu K; Lei M; Yang WQ; Wu LS; Shi JC; Zhang Y Int J Gynaecol Obstet; 2022 Jan; 156(1):159-165. PubMed ID: 33759181 [TBL] [Abstract][Full Text] [Related]
12. Value of endocervical margin and high-risk human papillomavirus status after conization for high-grade cervical intraepithelial neoplasia, adenocarcinoma in situ, and microinvasive carcinoma of the uterine cervix. Kong TW; Son JH; Chang SJ; Paek J; Lee Y; Ryu HS Gynecol Oncol; 2014 Dec; 135(3):468-73. PubMed ID: 25284039 [TBL] [Abstract][Full Text] [Related]
16. Intraoperative post-conisation human papillomavirus testing for early detection of treatment failure in patients with cervical intraepithelial neoplasia: a pilot study. Torné A; Fusté P; Rodríguez-Carunchio L; Alonso I; del Pino M; Nonell R; Cardona M; Rodríguez A; Castillo P; Pahisa J; Balasch J; Ramírez J; Ordi J BJOG; 2013 Mar; 120(4):392-9. PubMed ID: 23189989 [TBL] [Abstract][Full Text] [Related]
17. HPV-testing versus HPV-cytology co-testing to predict the outcome after conization. Bruhn LV; Andersen SJ; Hariri J Acta Obstet Gynecol Scand; 2018 Jun; 97(6):758-765. PubMed ID: 29430635 [TBL] [Abstract][Full Text] [Related]
18. Prediction of recurrence after treatment for high-grade cervical intraepithelial neoplasia: the role of human papillomavirus testing and age at conisation. Verguts J; Bronselaer B; Donders G; Arbyn M; Van Eldere J; Drijkoningen M; Poppe W BJOG; 2006 Nov; 113(11):1303-7. PubMed ID: 16978225 [TBL] [Abstract][Full Text] [Related]
19. Long-term risk of cervical cancer following conization of cervical intraepithelial neoplasia grade 3-A Danish nationwide cohort study. Sand FL; Frederiksen K; Munk C; Jensen SM; Kjaer SK Int J Cancer; 2018 May; 142(9):1759-1766. PubMed ID: 29218720 [TBL] [Abstract][Full Text] [Related]
20. An Abnormal Precone Endocervical Curettage Result Is an Independent Risk Factor for Positive Margins in Conization Specimens. An J; Lei H; Xie X; Sun P Oncol Res Treat; 2020; 43(10):518-525. PubMed ID: 32772026 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]